Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 13 studies | 28% ± 11% | |
astrocyte | 9 studies | 27% ± 9% | |
microglial cell | 8 studies | 25% ± 8% | |
oligodendrocyte | 8 studies | 27% ± 8% | |
fibroblast | 7 studies | 20% ± 5% | |
glutamatergic neuron | 6 studies | 39% ± 24% | |
epithelial cell | 6 studies | 34% ± 14% | |
GABAergic neuron | 5 studies | 35% ± 21% | |
pericyte | 5 studies | 20% ± 5% | |
basal cell | 5 studies | 29% ± 18% | |
neuron | 4 studies | 26% ± 13% | |
macrophage | 4 studies | 26% ± 5% | |
interneuron | 4 studies | 32% ± 19% | |
myeloid cell | 3 studies | 19% ± 2% | |
adipocyte | 3 studies | 19% ± 2% | |
ciliated cell | 3 studies | 20% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 6% | |
abnormal cell | 3 studies | 25% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 27% ± 6% | |
smooth muscle cell | 3 studies | 23% ± 1% | |
type I pneumocyte | 3 studies | 21% ± 6% | |
lymphocyte | 3 studies | 22% ± 4% | |
goblet cell | 3 studies | 31% ± 17% | |
transit amplifying cell | 3 studies | 37% ± 27% | |
cardiac muscle cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3263.82 | 1445 / 1445 | 100% | 31.17 | 183 / 183 |
intestine | 100% | 4083.71 | 966 / 966 | 100% | 20.93 | 525 / 527 |
skin | 100% | 4011.96 | 1809 / 1809 | 99% | 23.01 | 467 / 472 |
brain | 99% | 2975.57 | 2626 / 2642 | 99% | 25.02 | 700 / 705 |
stomach | 100% | 2570.09 | 359 / 359 | 99% | 23.66 | 282 / 286 |
lung | 100% | 3716.57 | 578 / 578 | 98% | 21.28 | 1136 / 1155 |
kidney | 100% | 2320.54 | 89 / 89 | 98% | 16.11 | 879 / 901 |
breast | 100% | 2868.84 | 459 / 459 | 96% | 14.59 | 1078 / 1118 |
adrenal gland | 100% | 4661.01 | 258 / 258 | 96% | 15.08 | 221 / 230 |
thymus | 100% | 2454.37 | 652 / 653 | 96% | 11.19 | 581 / 605 |
uterus | 100% | 5226.31 | 170 / 170 | 96% | 17.18 | 440 / 459 |
pancreas | 98% | 1825.29 | 321 / 328 | 97% | 13.47 | 173 / 178 |
prostate | 100% | 2834.00 | 245 / 245 | 95% | 11.16 | 477 / 502 |
bladder | 100% | 3312.05 | 21 / 21 | 93% | 14.58 | 471 / 504 |
ovary | 100% | 3636.36 | 180 / 180 | 93% | 13.53 | 401 / 430 |
liver | 88% | 937.49 | 200 / 226 | 55% | 4.26 | 222 / 406 |
adipose | 100% | 2911.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4201.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.94 | 29 / 29 |
muscle | 100% | 3183.97 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3062.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.78 | 45 / 45 |
heart | 98% | 2101.23 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 1493.61 | 773 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0042594 | Biological process | response to starvation |
GO_0061621 | Biological process | canonical glycolysis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXK1 |
Protein name | Forkhead box protein K1 (Myocyte nuclear factor) (MNF) Forkhead box K1 |
Synonyms | MNF |
Description | FUNCTION: Transcriptional regulator involved in different processes such as glucose metabolism, aerobic glycolysis, muscle cell differentiation and autophagy (By similarity). Recognizes and binds the forkhead DNA sequence motif (5'-GTAAACA-3') and can both act as a transcription activator or repressor, depending on the context . Together with FOXK2, acts as a key regulator of metabolic reprogramming towards aerobic glycolysis, a process in which glucose is converted to lactate in the presence of oxygen (By similarity). Acts by promoting expression of enzymes for glycolysis (such as hexokinase-2 (HK2), phosphofructokinase, pyruvate kinase (PKLR) and lactate dehydrogenase), while suppressing further oxidation of pyruvate in the mitochondria by up-regulating pyruvate dehydrogenase kinases PDK1 and PDK4 (By similarity). Probably plays a role in gluconeogenesis during overnight fasting, when lactate from white adipose tissue and muscle is the main substrate (By similarity). Involved in mTORC1-mediated metabolic reprogramming: in response to mTORC1 signaling, translocates into the nucleus and regulates the expression of genes associated with glycolysis and downstream anabolic pathways, such as HIF1A, thereby regulating glucose metabolism (By similarity). Together with FOXK2, acts as a negative regulator of autophagy in skeletal muscle: in response to starvation, enters the nucleus, binds the promoters of autophagy genes and represses their expression, preventing proteolysis of skeletal muscle proteins (By similarity). Acts as a transcriptional regulator of the myogenic progenitor cell population in skeletal muscle (By similarity). Binds to the upstream enhancer region (CCAC box) of myoglobin (MB) gene, regulating the myogenic progenitor cell population (By similarity). Promotes muscle progenitor cell proliferation by repressing the transcriptional activity of FOXO4, thereby inhibiting myogenic differentiation (By similarity). Involved in remodeling processes of adult muscles that occur in response to physiological stimuli (By similarity). Required to correct temporal orchestration of molecular and cellular events necessary for muscle repair (By similarity). Represses myogenic differentiation by inhibiting MEFC activity (By similarity). Positively regulates Wnt/beta-catenin signaling by translocating DVL into the nucleus . Reduces virus replication, probably by binding the interferon stimulated response element (ISRE) to promote antiviral gene expression . . |
Accessions | ENST00000460979.2 ENST00000328914.5 [P85037-1] U3KQ26 P85037 |